Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human SNPH ELISA Kit (AC2520)
Cat.#: ASET-1109
Specifications
Description Human SNPH ELISA Kit allows for the in vitro quantitative determination of human SNPH concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2341 Human Glutathione Synthetase ELISA Kit (AC3752) Quantitative inquiry ASET-2223 Human Acetylcholinesterase ELISA Kit (AC3634) Quantitative inquiry ASET-1368 Human NSMase2 ELISA Kit (AC2779) Quantitative inquiry ASET-1798 Human TMEM126A ELISA Kit (AC3209) Quantitative inquiry ASET-2215 Human Synaptopodin ELISA Kit (AC3626) Quantitative inquiry ASET-1334 Human CX3CR1 ELISA Kit (AC2745) Quantitative inquiry ASET-2160 Mouse Ndnf ELISA Kit (AC3571) Quantitative inquiry ASET-2372 Human GABA A Receptor alpha 1 ELISA Kit (AC3783) Quantitative inquiry ASET-1939 Mouse FOXO1A ELISA Kit (AC3350) Quantitative inquiry ASET-2364 Human Glutaminase ELISA Kit (AC3775) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket